Prevention of Vision Loss in Patients With Age-Related Macular Degeneration (AMD) by Intravitreal Injection of Bevacizumab and Ranibizumab
Clinical trial NCT00559715 · UNKNOWN
Trial details
- NCT number
- NCT00559715
- Sponsor
- Klinikum Bremen-Mitte, gGmbH
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2009-08-01
- Enrollment
- 366
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.